Literature DB >> 6219125

Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.

J E Merrill.   

Abstract

Though purported to be identical cells (or in identical populations of cells), the natural killer (NK) cell mediating spontaneous natural cytotoxicity and the killer (K) cell mediating antibody-dependent cellular cytotoxicity (ADCC) may not be totally identical, at least in susceptibility to regulation by the immunomodulators prostaglandin E1 (PGE1) and interferon (IFN). We demonstrate here that NK cells are always enhanced by IFN, while K cells are inhibited from binding targets, resulting in fewer effectors at optimal concentrations of antibody. Only at 10- to 100-fold suboptimal concentrations of antibody is ADCC activity enhanced. As measured by magnitude of inhibition and dose-response titration, ADCC activity is less sensitive to the effects of PGE1 than is NK activity in the 51Cr release assay and single-cell assay. After overnight incubation with or without PGE1, whatever sensitivity ADCC activity had to PGE1 is lost. However, NK cells incubated in the presence of PGE1 overnight are still sensitive to inhibition. Indomethacin boosts NK activity without having any effect on ADCC activity. Finally, NK activity is substantially reduced by overnight incubation of cells at room temperature, which has no effect on K cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219125     DOI: 10.1007/bf00919137

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  37 in total

1.  Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency.

Authors:  E Grimm; B Bonavida
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

2.  Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes.

Authors:  M P Nair; S A Schwartz
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

3.  Heterogeneity within the population of NK and K cells.

Authors:  P J Jensen; H S Koren
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

4.  Monocyte-induced human natural killer cell suppression followed by increased cytotoxic activity during short-term in vitro culture in autologous serum.

Authors:  M Jondal; J Merrill; M Ullberg
Journal:  Scand J Immunol       Date:  1981-11       Impact factor: 3.487

5.  Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations.

Authors:  J D Stobo; M S Kennedy; M E Goldyne
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

6.  gamma-Interferon induced by S. aureus protein A augments natural killing and ADCC.

Authors:  W J Catalona; T L Ratliff; R E McCool
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

7.  Interferon enhances the expression of Fc gamma receptors.

Authors:  W H Fridman; I Gresser; M T Bandu; M Aguet; C Neauport-Sautes
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

8.  Natural killing in immunodeficient patients.

Authors:  H S Koren; D B Amos; R H Buckley
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

9.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  Recycling and target binding capacity of human natural killer cells.

Authors:  M Ullberg; M Jondal
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  1 in total

1.  Enhanced K-cell activity in the peripheral blood of patients with malignant disease.

Authors:  T Bakács; P Czanik; I Kimber; G Ringwald; M Moore; E Abrahám
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.